The 30-year-old Queens resident started gaining weight during the COVID pandemic as her lifestyle became more sedentary
The pill and the injection are not different drugs with different chemistry
Record the final concentration, diluent, preparation date, and storage condition
GLP-1 agonists commonly cause nausea, vomiting, diarrhea, and abdominal painsymptoms that overlap with Crohn's disease
Realistic Results Timeline (What to Actually Expect) Week 12: Energy Shift Most users report slightly better workout endurance and reduced mid-exercise fatigue
The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8